A whale with a lot of money to spend has taken a noticeably bullish stance on Amgen.
Looking at options history for Amgen AMGN we detected 11 strange trades.
If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and 45% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $147,365 and 9, calls, for a total amount of $451,549.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $220.0 to $250.0 for Amgen over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Amgen options trades today is 596.57 with a total volume of 2,905.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Amgen's big money trades within a strike price range of $220.0 to $250.0 over the last 30 days.
Amgen Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| AMGN | PUT | TRADE | BEARISH | 01/19/24 | $230.00 | $108.5K | 1.1K | 0 |
| AMGN | CALL | SWEEP | BEARISH | 01/19/24 | $240.00 | $105.1K | 521 | 98 |
| AMGN | CALL | SWEEP | BULLISH | 06/16/23 | $227.50 | $68.4K | 31 | 182 |
| AMGN | CALL | SWEEP | BULLISH | 06/16/23 | $227.50 | $52.5K | 31 | 621 |
| AMGN | CALL | SWEEP | BULLISH | 06/16/23 | $227.50 | $48.0K | 31 | 308 |
Where Is Amgen Standing Right Now?
- With a volume of 1,095,636, the price of AMGN is up 0.74% at $225.64.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 72 days.
What The Experts Say On Amgen:
- Oppenheimer downgraded its action to Outperform with a price target of $280
- Oppenheimer has decided to maintain their Outperform rating on Amgen, which currently sits at a price target of $290.
- RBC Capital downgraded its action to Sector Perform with a price target of $254
- Piper Sandler has decided to maintain their Overweight rating on Amgen, which currently sits at a price target of $288.
- Barclays has decided to maintain their Underweight rating on Amgen, which currently sits at a price target of $225.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Amgen, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
